DIBOLL — Council members learned that Diboll has recovered nearly $80,000 in delinquent taxes between July and November, as the city’s longtime collection firm reported Tuesday, while also adopting a ...

FIRST ON FOX: Secretary of the Treasury Scott Bessent scrapped Biden-era coin designs intended to celebrate the 250th anniversary of America’s founding after the Trump administration discovered they ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Advanced practice providers have been on strike since Dec. 2. Darcelle XV carries on drag queen's legacy by giving back through Christmas Eve dinner Volunteers and employees of Darcelle XV in Portland ...

To redeem a link, click on it. Doing so redirects you to the Coin Master app. Note that you’ll need to do this on the same phone, tablet, or other device where you’ve installed the app. Make sure ...

Archaeologists excavating the remains of Guanzhuang—an ancient city in China’s eastern Henan Province—have discovered what they believe is the oldest-known coin mint, where miniature, shovel-shaped ...

New coins will bring a change to your pocket change in 2026. The United States Mint is set to roll out five new quarters and a dime to mark the nation's 250th anniversary. Officials unveiled the coins ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Democratic senators have introduced legislation to prohibit the United States Mint from striking a commemorative coin featuring the likeness of President Donald Trump, citing concerns that the move ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...